Lukewarm reception for Rain, Impel as IPO queue swells further

The IPO queue continued to grow this week behind the two biotechs that began trading Friday, as Rain swiftly gave back early double-digit gains while Impel mostly traded close to its offering price.

Both Rain Therapeutics Inc. (NASDAQ:RAIN) and Impel Neuropharma Inc. (NASDAQ:IMPL) priced the expected number of shares in the middle of their proposed ranges...